Primary biliary cholangitis in Thai woman: A case report

Authors

  • Likhasit Sanglutong Thammasat University Hospital, Pathum Thani, Thailand
  • Somchai Insiripong Marahat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand

Keywords:

Primary biliary cholangitis, anti-mitochondrial antibody

Abstract

Primary biliary cholangitis or primary biliary cirrhosis (PBC) is a chronic, slowly progressive, autoimmune, cholestatic liver disease. It is globally considered a rare disease. Herein, we presented a 55-year-old Thai woman who gradually developed fatigue and generalized pruritis without fever for four months. Her physical examination revealed only pallor and jaundice, no liver stigmata, and no hepatosplenomegaly; her blood tests showed: Hb 8.1 g/dL, WBC 12,180/mm3, platelet 143,000/mm3, albumin 2.2 g/dL, globulin 4.0 g/dL, AST 164 U/L, ALT 102 U/L, alkaline phosphatase 384 U/L, total bilirubin 2.8 mg/dL, direct bilirubin 1.3 mg/dL, HBV, HCV and HIVnegative, ferritin 39.9 ng/ml, copper 125 ug/dL, ceruloplasmin 0.27 g/L, urine copper < 1 ug/g creatinine, antismooth muscle antibody-negative, anti-mitochondrial antibody-positive 1:1,600, ANA-positive, homogeneous pattern 1:80, centromere pattern 1:1,280, anti-cytoplasmic antibody-positive 1:1,280, alpha fetoprotein 3.16 ng/ml, creatinine 0.55 mg%, and normal coagulogram. Ultrasonography and the computerized tomography of the upper abdomen showed nodularity and heterogeneous parenchymal disease of the liver, no intrahepatic bile duct dilatation, and slight splenomegaly, compatible with cirrhosis. Esophagogastroduodenoscopy showed acute esophageal variceal bleeding that was successfully treated with rubber band ligation. The diagnosis of PBC was concluded and she was treated with ursodeoxycholic acid and propranolol. Within 6 months, her clinical symptoms as well as transaminitis partially improved.

Downloads

Download data is not yet available.

References

Purohit T, Cappell MS. Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World J Hepatol 2015;7:926-41. https://doi.org/10.4254/wjh.v7.i7.926

Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet 2015;386:1565-75.

https://doi.org/10.1016/S0140-6736(15)00154-3

Bowlus CL, Gershwin ME. The diagnosis of primary biliary cirrhosis. Autoimmun Rev 2014;13:441-4.

https://doi.org/10.1016/j.autrev.2014.01.041

Nguyen DL, Juran BD, Lazaridis KN. Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol 2010;24: 647-54. https://doi.org/10.1016/j.bpg.2010.07.006

Pandit S, Samant H. Primary biliary cholangitis (primary biliary cirrhosis). In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2018 [cited 2018 Sep 27]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459209/.

Juran BD, Lazaridis KN. Environmental factors in primary biliary cirrhosis. Semin Liver Dis 2014;34:265-72. https://doi.org/10.1055/s-0034-1383726

Chainuvati T, Viranuvatti V, Damrongsak C, Hitanant S, Chearanai O. Primary biliary cirrhosis report of 3 cases in Thailand. J Med Assoc Thai 1973;56:130-9.

Kim KA, Jeong SH. The diagnosis and treatment of primary biliary cirrhosis. Korean J Hepatol 2011;17:173-9. https://doi.org/10.3350/kjhep.2011.17.3.173

Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:85-91. https://doi.org/10.3238/arztebl.2013.0085

Poupon R. Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation. Hepatology 2015;61:2080-90. https://doi.org/10.1002/hep.27715

Longo M, Crosignani A, Battezzati PM, Squarcia GC, Invernizzi P, Zuin M, et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002;51:265-9.

https://doi.org/10.1136/gut.51.2.265

Floreani A, Franceschet I, Cazzagon N, Spinazze A, Buja A, Furlan P, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 2015;48:192-7.

https://doi.org/10.1007/s12016-014-8427-x

Tanaka A, Miyakawa H, Luketic VA, Kaplan M, Storch WB, Gershwin ME. The diagnostic value of antimitochondrial antibodies, especially in primary biliary cirrhosis. Cell Mol Biol (Noisy -le-grand) 2002;48:295-9.

Zuber MA, Recktenwald C. Clinical correlation of antimitochondrial antibodies. Eur J Med Res 2003;8: 61-70.

Liu B, Shi XH, Zhang FC, Zhang W, Gao LX. Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis. Liver Int 2008;28:233-9.

https://doi.org/10.1111/j.1478-3231.2007.01651.x

Satoh M, Vazquez-Del Mercado M, Chan EK. Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol 2009;19:219-28.https://doi.org/10.3109/s10165-009-0155-3

Liberal R, Grant CR, Sakkas L, Bizzaro N, Bogdanos DP. Diagnostic and clinical significance of anticentromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol 2013;37:572-85.

https://doi.org/10.1016/j.clinre.2013.04.005

Suraweera D, Rahal H, Jimenez M, Viramontes M, Choi G, Saab S. Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review. Liver Int 2017;37:1877-86.

https://doi.org/10.1111/liv.13477

Downloads

Published

2023-07-20

How to Cite

1.
Sanglutong L, Insiripong S. Primary biliary cholangitis in Thai woman: A case report. Chula Med J [Internet]. 2023 Jul. 20 [cited 2024 Oct. 12];64(1). Available from: https://he05.tci-thaijo.org/index.php/CMJ/article/view/186